Rituximab for chronic immune thrombocytopenic purpura.
Bay
Ali
A
Oner
Ahmet Faik
AF
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D002648:Child; D002908:Chronic Disease; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*; D019233:Retreatment; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007155:Immunologic Factors; D000069283:Rituximab